Pulse - Out with the New, In with Old: Warfarin versus DOACS in Thrombotic Antiphospholipid Syndrome
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Anticoagulation is a cornerstone of treatment for antiphospholipid syndrome. The goal of this study is to describe the data amongst available trials supporting anticoagulation with warfarin or a direct oral anticoagulant.
Target Audience
Pharmacist
Learning Objectives
Define the disease state of thrombotic antiphospholipid syndrome (APS) in relation to diagnosis
Describe the data amongst available trials examining the utilization of direct oral anticoagulants (DOACs) versus warfarin in thrombotic APS
Explain an anticoagulation treatment plan based around the current literature for a patient diagnosed with thrombotic APS
Additional Information
Attachment | Size |
---|---|
![]() | 460.3 KB |
![]() | 16.32 KB |
![]() | 137.61 KB |
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Anticoagulation is a cornerstone of treatment for antiphospholipid syndrome. The goal of this study is to describe the data amongst available trials supporting anticoagulation with warfarin or a direct oral anticoagulant.
Josh Dorazio, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.